Cheetah Medical’s French Distributor SEBAC SA to Supply Starling SV Monitoring Systems to Paris’ Public Hospital System

NEWTON, Mass.–(BUSINESS WIRE)–Cheetah Medical, a Massachusetts-based leader in non-invasive fluid
management devices, today announced that its French distributor, SEBAC
SA, has been awarded the contract to supply Starling SV non-invasive
fluid management solutions to the public hospital system of Paris and
its suburbs. The four-year deal with Assistance Publique des Hopitaux de
Paris (APHP), with an estimated value of $3.6M (€3M), calls for the
Starling SV Hemodynamic Monitoring System, a 100 percent noninvasive
hemodynamic monitoring system used for volume management and perfusion
optimization, to be installed in more than 40 hospitals around Greater
Paris.

The 2013 guidelines issued by the Société Française d ‘anesthesie et de
Réanimation (SFAR) stress the need for continuous monitoring of a
high-risk patient’s stroke volume to guide fluid management during and
after surgery. Previously, only a minority of operating rooms were
equipped with a hemodynamic monitoring system, primarily due to the
complexity of available systems and their invasive and labor-intensive
application.

By contrast, the Starling SV Hemodynamic Monitoring System is
non-invasive, measuring blood flow centrally and favorably validated
against more invasive methods including the Swan Ganz catheter1.In addition to measurement accuracy, the Starling SV Hemodynamic
Monitoring system is as easy to use as an ECG recording machine — no
calibration, no positing and repositioning of probes are needed.

“The adoption of the SFAR 2013 guidelines will take a significant step
forward now that physicians at Parisien and suburban public hospitals
have a simple and easy to use monitor to help guide clinical
decision-making,” said Doug Hansell, M.D., Chief Physician Executive at
Cheetah Medical. “Proper fluid management has been shown to reduce
surgical complications and improve patient outcomes. Together with our
partner SEEBAC SA, we are thrilled that APHP has made a commitment to
ensure this modern technology is in place in all of its hospitals in
Paris and surrounding suburbs.”

The Cheetah Starling™ SV system is designed to give clinicians the full
hemodynamic picture of their patient. Because the device measures
centrally, it provides accurate and precise hemodynamic data straight
from the source, unlike traditional measures that indirectly assess
hemodynamics by measuring blood pressure, end organ function (urine
output, mentation) or biomarkers such as lactate. Details about the
Cheetah Starling™ SV monitoring technology can be found at www.cheetah-medical.com.

About Cheetah Medical
Cheetah
Medical is the pioneer and leading global provider of 100 percent
non-invasive fluid management monitoring technologies, designed for use
in critical care, operating room and emergency department settings. The
CHEETAH Starling™ SV is fast becoming the gold standard in fluid
management, as it provides immediate, dynamic assessments of fluid
responsiveness, enabling clinicians to make more confident and informed
treatment for their patients. Moreover, recent research from the
University of Kansas Medical Center has shown effective fluid management
can reduce hospital ICU stays by an average of 2.89 days, reduce risk of
mechanical ventilation and initiation of acute dialysis, saving over
$14,000 in medical costs per patient. The company’s fluid
management systems currently make an impact in more than 400 hospitals
throughout the U.S. and in 30 countries worldwide.

1 Squara P, Denjean D, Estagnasie P, Brusset A, Dib J, Dubois
C. Noninvasive cardiac output monitoring (NICOM): a clinical validation.
Intensive Care Medicine 2007; 33: 1191-1194.

Contacts

Cheetah Medical
Maayan Wenderow, 617-964-0663
maayan@cheetah-medical.com
or
JPA
Health Communications
Melissa Baron, 617-657-1312
mbaron@jpa.com